IC

Ikarian Capital Portfolio holdings

AUM $494M
1-Year Est. Return 153.64%
This Quarter Est. Return
1 Year Est. Return
+153.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$672M
AUM Growth
+$124M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
266
New
Increased
Reduced
Closed

Top Buys

1
+$23.4M
2
+$15.9M
3
+$15.5M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$15.4M
5
RLMD icon
Relmada Therapeutics
RLMD
+$10.2M

Top Sells

1
+$29.5M
2
+$19.7M
3
+$18.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
5
CLDX icon
Celldex Therapeutics
CLDX
+$15.8M

Sector Composition

1 Healthcare 98.54%
2 Consumer Staples 0.23%
3 Financials 0.12%
4 Industrials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
126
$1.12M 0.04%
+19,547
127
$1.1M 0.04%
136,142
-23,858
128
$949K 0.03%
51,273
-50,000
129
$914K 0.03%
40,913
-100,000
130
$911K 0.03%
+119,803
131
$836K 0.03%
+15,000
132
$820K 0.03%
85,837
-165,000
133
$808K 0.03%
+35,000
134
$794K 0.03%
75,100
+75,000
135
$769K 0.03%
219,109
136
$766K 0.03%
+75,000
137
$757K 0.03%
100,000
138
$748K 0.03%
10,000
139
$693K 0.02%
+119,551
140
$649K 0.02%
+3
141
$622K 0.02%
231
+222
142
$595K 0.02%
16,883
143
$558K 0.02%
8,430
+4,214
144
$546K 0.02%
43,915
-68,797
145
$536K 0.02%
+1,130
146
$533K 0.02%
54,901
147
$478K 0.02%
2,636
148
$441K 0.01%
15,603
+4,400
149
$419K 0.01%
1,146,308
150
$410K 0.01%
+48,053
4 5
6
7 8